The first rule: your cancer team agrees before anything starts
Testosterone after prostate cancer is a decision made with your urologist or oncologist, not around them. The AUA guideline tells clinicians to inform men with a history of prostate cancer that there is inadequate evidence to quantify the risk and benefit of testosterone therapy. The Endocrine Society guideline goes further and recommends against starting testosterone in men with prostate cancer.
Those are cautious positions, and they should be. Some urologists do consider treatment for carefully selected men after curative surgery or radiation whose PSA has stayed low, but that judgment belongs to the specialist who knows your pathology, stage and margins. A men’s health clinic can evaluate symptoms and labs; it should not overrule the cancer team.
Some situations are outside this conversation altogether:
- Men currently on androgen deprivation therapy, which lowers testosterone deliberately
- Men with a rising or persistently detectable PSA after treatment
- Men with cancer that has spread beyond the prostate
- Men whose cancer team has not yet confirmed treatment was successful
What a stable, low PSA means after surgery or radiation
The PSA target depends on how the cancer was treated, so the treating team defines what “stable” means for you. After a radical prostatectomy, the prostate is gone, and PSA should fall to an undetectable or near-undetectable level. In a series of 103 men treated after prostatectomy, median PSA before starting testosterone was 0.004 ng/mL, and men began a median of about 12 months after surgery.
After radiation or seed implants, the prostate stays in place and PSA usually drifts down more slowly before settling. In a study of 31 men treated after brachytherapy, testosterone was started a median of 2 years after the seeds were placed. Your oncologist decides when the curve has flattened enough to call it stable.
Confirming low testosterone after cancer treatment
Fatigue, low desire and weaker erections are common after prostate cancer treatment, and many of them have nothing to do with testosterone. Surgery and radiation affect nerves and blood flow, the diagnosis itself takes an emotional toll, and men coming off hormone therapy may still be recovering their own production. So the diagnosis is confirmed the same careful way it is for any man, with two early-morning testosterone results below the guideline range and symptoms that fit.
LH and FSH help show whether the testes or the pituitary signal is the weak link, and a complete blood count and estradiol complete the baseline. If you recently finished androgen deprivation therapy, your cancer team may want to wait and retest, since testosterone can take time to come back on its own. Treating a number that was still recovering would add risk for no reason.
What the evidence shows so far
The data on testosterone after prostate cancer come mainly from small, retrospective studies, and they are reassuring but limited. In the prostatectomy series, PSA rose modestly on testosterone, yet recurrences were not more common than in a comparison group: 4 in the treated group versus 8 in the reference group. The authors still called for a “vigorous surveillance protocol.”
In the brachytherapy study, men were treated for a median of 4.5 years, and no one stopped because of cancer recurrence or progression. The most recent PSA was below 0.1 ng/mL in 23 of 31 men. These are encouraging signals, not proof. The Endocrine Society’s 2026 statement notes that long-term safety, including for prostate cancer, remains unestablished, because prostate cancer develops slowly and trials may not follow men long enough.
Monitoring: PSA every three months in the first year
Monitoring after prostate cancer is tighter than for other men on testosterone. Routine survivorship care already checks PSA often: the American Cancer Society says most doctors recommend PSA tests about every 6 months for the first 5 years after treatment. In the prostatectomy series, PSA was checked every 3 to 6 months after testosterone began.
For the first year on treatment, this plan uses the three-month end of that range, agreed with your specialist:
| Time on treatment | What is checked | Who sees the results |
|---|---|---|
| Before starting | PSA, testosterone, CBC, estradiol | You, the clinic and your urologist or oncologist |
| Every 3 months in year one | PSA, testosterone, hematocrit | Shared with your cancer team |
| After year one | Interval agreed with your specialist | Shared with your cancer team |
Any confirmed rise in PSA means pausing and going back to the specialist, not adjusting the dose and waiting. Our page on a rising PSA on TRT explains what that review looks like.
Erections after treatment are handled alongside
Erectile function is often the bigger day-to-day concern after prostate cancer treatment, and testosterone on its own rarely solves it. Nerve and blood vessel changes from surgery or radiation are usually the main cause. That is why erection recovery runs on its own track, at the same time as any hormone discussion.
Options at the clinic include oral ED medicines and, when pills fall short, injectable medicines such as Trimix injections. Our pages on ED after prostatectomy and ED after prostate radiation explain what recovery tends to look like with each treatment.
Questions to bring to your urologist or oncologist
- By your own standards, is my cancer controlled well enough for testosterone to be discussed?
- What PSA level would make you want me to stop immediately?
- Would you prefer a particular form of testosterone, and how often do you want PSA checked?
- Who should receive copies of my lab results?
- Should erection recovery start now, regardless of the hormone decision?
How Ultimate Male works with your cancer team
At Ultimate Male, a man with a history of prostate cancer starts like anyone else, with the free phone call, but the plan changes immediately. Before testosterone is discussed, the provider will want your pathology report, treatment summary and every PSA since treatment, plus written agreement from your urologist or oncologist. Labs are drawn on site at San Gabriel or Downey, and results can be sent to your specialist.
If your team is not supportive, the conversation shifts to symptoms that can be helped without testosterone, including ED care. Your consultation is an assessment of whether treatment is safe for you, not a commitment to start it. Read more about testosterone therapy and how the clinic monitors it.
